Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Freeman Spogli & Co. is a leading middle-market private equity firm that specializes in investing in consumer and distribution companies, including those in the healthcare services and medical products sectors. Founded in 1983, the firm partners with experienced management teams to provide growth capital and strategic guidance to established businesses with strong market positions. Their healthcare investment strategy typically focuses on service providers, specialized distributors, and retail-oriented health companies rather than early-stage drug discovery or biotechnology. The firm operates out of offices in Los Angeles and New York, managing billions of dollars in committed capital across multiple investment funds. Notable healthcare-related investments have included companies such as US Renal Care, Health-E Commerce, and Regent Surgical Health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Freeman Spogli & Co..